Dolby Laboratories, Inc. — Director's Dealing 2021

Aug 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2021-08-17

Reporting Person: CHEW LEWIS (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-17	Class A Common Stock	M	30000	$33.15	Acquired	135598	Direct
2021-08-17	Class A Common Stock	S	2800	$101.6754	Disposed	132798	Direct
2021-08-17	Class A Common Stock	S	4900	$100.824	Disposed	127898	Direct
2021-08-17	Class A Common Stock	S	14870	$99.6483	Disposed	113028	Direct
2021-08-17	Class A Common Stock	S	7430	$99.1965	Disposed	105598	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-17	Employee Stock Option (right to buy)	$33.15	M	30000	Disposed	2022-12-15	Class A Common Stock (30000)	Direct

Footnotes

F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest.

F2: The shares were sold in multiple transactions at prices ranging from $101.37 to $102.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: The shares were sold in multiple transactions at prices ranging from $100.36 to $101.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: The shares were sold in multiple transactions at prices ranging from $99.31 to $100.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $99.15 to $99.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This performance-based stock option award was granted for a total of 32,500 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 40,625 shares.